Follow the 강스템바이오텍 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 강스템바이오텍 has published 97 insider filings. Market capitalisation: €206bn. The latest transaction was filed on 12 March 2026 (Other). Among the most active insiders: 나종천. All data is openly available.
97
Insider Decl.
n/a
Thresholds
n/a
8 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,667 of 28,065 companies
20.2
score / 100
Value
21
Quality
19
FCF yld-6.0%
Earn yld-5.1%
EV/EBITDA·
ROE-48%
Gross mgn24%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.